These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11041739)

  • 1. From the Centers for Disease Control and Prevention. Recall of isoniazid used for antimicrobial susceptibility testing for tuberculosis.
    JAMA; 2000 Oct; 284(13):1642-7. PubMed ID: 11041739
    [No Abstract]   [Full Text] [Related]  

  • 2. Recall of isoniazid used for antimicrobial susceptibility testing for tuberculosis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Sep; 49(34):780-2. PubMed ID: 10987246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of and treatment protocol for rifampicin-monoresistant tuberculosis: what is the role of isoniazid?
    Velayati AA; Farnia P; Masjedi MR; Hoffner S
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):849-50. PubMed ID: 23676176
    [No Abstract]   [Full Text] [Related]  

  • 4. Expanding the role of the microscopic observation drug susceptibility assay in tuberculosis and HIV management.
    Minion J; Pai M
    Clin Infect Dis; 2010 Apr; 50(7):997-9. PubMed ID: 20192726
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid].
    Mitarai S; Kobayashi I; Abe C; Wada M; Suzuki K; Takashima T; Kawabe Y; Machida K; Tano M; Takigawa S; Kamada A; Shigetoh E; Fujii S; Mori K; Suyama H; Yano S; Kawashiro T; Ogata H
    Kekkaku; 2007 May; 82(5):449-54. PubMed ID: 17564123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The bacteriological principles of tuberculosis treatments].
    Grosset J
    Rev Prat; 1979 Jun; 29(33):2645-50. PubMed ID: 113863
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.
    Lounis N; Maslo C; Truffot-Pernot C; Grosset J; Boelaert RJ
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):575-9. PubMed ID: 12797701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental data on the antimicrobial activity of Isoprodian (PTH).
    Urbanczik R
    Scand J Respir Dis Suppl; 1978; 102():58-9. PubMed ID: 98838
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the potential role of a new mutation in mabA in modifying the response of Mycobacterium tuberculosis to isoniazid.
    Alonso M; Martínez-Lirola M; Palacios JJ; Menéndez Á; Herranz M; Martínez S; Bouza E; García-de-Viedma D
    Tuberculosis (Edinb); 2013 Nov; 93(6):664-7. PubMed ID: 23973657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs for tuberculosis.
    Treat Guidel Med Lett; 2004 Dec; 2(28):83-8. PubMed ID: 15557876
    [No Abstract]   [Full Text] [Related]  

  • 11. [Incidence of resistant mutants of Mycobacterium tuberculosis (MT) strains from different areas of Rumania. Bacteriological study--epidemiological aspects].
    Anastasatu C; Băicoianu S; Teodorescu A
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):212-22. PubMed ID: 4998673
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutting costs on mono-resistant tuberculosis diagnosis could eventually end up being more expensive.
    Rouzaud F; Robledo J
    Indian J Med Microbiol; 2010; 28(4):412-3. PubMed ID: 20966587
    [No Abstract]   [Full Text] [Related]  

  • 13. Reliability of Mycobacterial Growth Indicator Tube (MGIT) 960 for the detection of isoniazid resistance in a tuberculosis endemic setting.
    Gomathi NS; Kumar V
    Indian J Med Res; 2014 Mar; 139(3):471-3. PubMed ID: 24820845
    [No Abstract]   [Full Text] [Related]  

  • 14. [Emergent strains of rifampicin-resistant Mycobacterium tuberculosis complex and susceptibility to isoniazid].
    Cacho-Calvo J; Martín-Díaz A;
    Enferm Infecc Microbiol Clin; 2013; 31(7):486-7. PubMed ID: 23623580
    [No Abstract]   [Full Text] [Related]  

  • 15. Microplate hybridization assay for detection of isoniazid resistance in Mycobacterium tuberculosis.
    Han HE; Lee IS; Hwang JH; Bang HE; Kim Y; Cho SN; Kim TU; Lee HY
    BMB Rep; 2009 Feb; 42(2):81-5. PubMed ID: 19250607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoniazid minimal inhibitory concentrations of tuberculosis strains with katG mutation.
    Otto-Knapp R; Vesenbeckh S; Schönfeld N; Bettermann G; Roth A; Bauer T; Rüssmann H; Mauch H
    Int J Tuberc Lung Dis; 2016 Sep; 20(9):1275-6. PubMed ID: 27510258
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazid.
    Hearn MJ; Cynamon MH; Chen MF; Coppins R; Davis J; Joo-On Kang H; Noble A; Tu-Sekine B; Terrot MS; Trombino D; Thai M; Webster ER; Wilson R
    Eur J Med Chem; 2009 Oct; 44(10):4169-78. PubMed ID: 19524330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Resistance to antitubercular drugs in Chile].
    Valenzuela MT; Scheel G; Ponce J; Lepe R; Velasco M; Valenzuela P
    Rev Med Chil; 1984 Jan; 112(1):76-80. PubMed ID: 6429808
    [No Abstract]   [Full Text] [Related]  

  • 19. [Molecular medicine and treatment of tuberculosis].
    Perel'man MI; Khomiakov IuN; Kiselev VI; Severin ES; Pal'tsev MA
    Probl Tuberk; 2001; (5):5-7. PubMed ID: 11588966
    [No Abstract]   [Full Text] [Related]  

  • 20. Respirable rifampicin-based microspheres containing isoniazid for tuberculosis treatment.
    Cassano R; Trombino S; Ferrarelli T; Mauro MV; Giraldi C; Manconi M; Fadda AM; Picci N
    J Biomed Mater Res A; 2012 Feb; 100(2):536-42. PubMed ID: 22162280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.